Results 281 to 290 of about 211,280 (349)

Stent-assisted coiling for ruptured anterior choroidal artery aneurysms: A retrospective observational study evaluating safety, efficacy, and antiplatelet strategies. [PDF]

Medicine (Baltimore)
He L, Zhu W, Liu Y, Huang Y.
europepmc   +1 more source

Antithrombotic Therapy and Bleeding Risk Among Young Adults After Ischemic Stroke.

JAMA Netw Open
Rasing A, Verburgt E, Ekker MS, Schellekens MMI, Immens MHM, Verhoeven JI, Boot EM, van Alebeek ME, Brouwers PJAM, Arntz RM, van Dijk GW, van Uden IWM, Gons RAR, den Heijer T, van Tuijl JH, de Laat KF, van Norden AGW, Vermeer SE, van Zagten MSG, van Oostenbrugge RJ, Wermer MJH, Nederkoorn PJ, Kerkhoff H, Rooyer FA, van Rooij FG, van den Wijngaard IR, Ten Cate TJF, Tuladhar AM, Richard E, de Leeuw FE, Hilkens NA.   +30 more
europepmc   +1 more source

P2Y12 Inhibitors and Mortality in Patients Hospitalized With Intracerebral Hemorrhage.

JAMA Netw Open
Jin C, Song Y, Mac Grory B, Sun JL, Alhanti B, Fonarow GC, Schwamm LH, Sheth KN, Smith EE, Messé SR, Saver JL, Bhatt DL, Xian Y.   +12 more
europepmc   +1 more source

Antiplatelet Therapy in Neurointervention

Seminars in Neurology, 2023
AbstractThe aim of this review is to provide an overview of the use of antiplatelet medication in neurointervention, with a focus on the clinical indications for antiplatelet use in both preventing and reducing platelet aggregation. This review will cover current antiplatelet medications, pharmacokinetics, and pharmacodynamics.
Alice Ma, Harshil Dharamdasani Detaram, Brendan Steinfort, Tim Harrington, Thanh N. Nguyen, Mohamad Abdalkader, George Siopis, Philip M. Bath, Permesh Singh Dhillon, Anna Podlasek, Adnan I. Qureshi, Zhongming Qiu, Kailash Krishnan   +12 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Personalised antiplatelet therapies for coronary artery disease: what the future holds

European Heart Journal, 2023
Coronary artery disease (CAD) is one of the leading causes of death globally, and antiplatelet therapy is crucial for both its prevention and treatment.
Dominick Angiolillo
exaly   +2 more sources

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Circulation, 2023
Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome ...
D. Capodanno, R. Mehran, M. Krucoff, U. Baber, Deepak L. Bhatt, P. Capranzano, J. Collet, T. Cuisset, G. De Luca, L. De Luca, A. Farb, Francesco Franchi, C. Gibson, J. Hahn, M. Hong, S. James, A. Kastrati, T. Kimura, P. Lemos, R. Lopes, A. Magee, R. Matsumura, Shuichi Mochizuki, M. O’Donoghue, N. Pereira, Sunil V. Rao, F. Rollini, Y. Shirai, D. Sibbing, P. Smits, P. Steg, R. Storey, J. T. ten Berg, M. Valgimigli, P. Vranckx, Hirotoshi Watanabe, S. Windecker, P. Serruys, R. Yeh, M. Morice, D. Angiolillo   +40 more
semanticscholar   +1 more source

Antiplatelet drugs

European Journal of Clinical Investigation, 1994
Abstract.The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists.
G A, Fitzgerald, E A, Meagher
openaire   +2 more sources

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

The Lancet, 2021
BACKGROUND Whether guided selection of antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) is effective in improving outcomes compared with standard antiplatelet therapy remains controversial.
M. Galli, S. Benenati, D. Capodanno, Francesco Franchi, F. Rollini, D. D'Amario, I. Porto, D. Angiolillo   +7 more
semanticscholar   +1 more source

Antiplatelet agents

Hematology, 2009
Abstract The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeutic approach in cardiovascular medicine. Since platelets play a key role in the development of arterial thrombosis, antiplatelet drugs serve as a cornerstone in the prevention and the treatment of these conditions.
David, Varon, Galia, Spectre
openaire   +2 more sources

Antiplatelet drugs

Medical Journal of Australia, 1999
Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is ...
R I, Baker, G J, Hankey
openaire   +3 more sources